These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2194186)

  • 41. Computer-assisted classification and diagnosis of liver disease.
    Fraser PM; Baron DN
    Proc R Soc Med; 1966 Aug; 59(8):776-9. PubMed ID: 5911444
    [No Abstract]   [Full Text] [Related]  

  • 42. [Classification of suppurative diseases of the liver].
    Babaev OG; Milonov OB
    Khirurgiia (Mosk); 1971 Jul; 47(7):58-60. PubMed ID: 5118907
    [No Abstract]   [Full Text] [Related]  

  • 43. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Taxonomic procedures applied to liver disease.
    Fraser PM; Baron DN
    Proc R Soc Med; 1968 Oct; 61(10):1043-6. PubMed ID: 5682632
    [No Abstract]   [Full Text] [Related]  

  • 45. Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
    Ferré N; Marsillach J; Camps J; Mackness B; Mackness M; Riu F; Coll B; Tous M; Joven J
    J Hepatol; 2006 Jul; 45(1):51-9. PubMed ID: 16510204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Nomenclature and classification of the most important liver diseases].
    Hauftová D
    Cesk Gastroenterol Vyz; 1982 Sep; 36(6):289-95. PubMed ID: 7139735
    [No Abstract]   [Full Text] [Related]  

  • 47. [Vague symptomatic--the crux of liver diseases.L.Weber, M.D. of Vilshofen explains a plan for liver diagnosis].
    Weber L
    Fortschr Med; 1999 Apr; 117(10):16-8. PubMed ID: 10384740
    [No Abstract]   [Full Text] [Related]  

  • 48. [Hepatorenal fibrocystic disease].
    Sánchez J; Contreras F; Patrón M; Calvo M
    Rev Clin Esp; 1971 Apr; 121(2):137-46. PubMed ID: 5561945
    [No Abstract]   [Full Text] [Related]  

  • 49. Hepatolithiasis in Japan.
    Uchiyama K; Tanimura H; Ishimoto K
    Nihon Geka Hokan; 1996 Nov; 65(4):145-57. PubMed ID: 9528273
    [No Abstract]   [Full Text] [Related]  

  • 50. Epidemiology and characteristics of liver diseases in an immigrant population attending a nongovernmental organization (NGO) in Milan.
    Colucci G; Masciulli A; Colombo M
    Dig Liver Dis; 2017 Feb; 49(2):229-230. PubMed ID: 28065632
    [No Abstract]   [Full Text] [Related]  

  • 51. [Liver biopsy in ambulatory patients. Diagnostic value in comparison to conventional and quantitative liver function tests].
    Giger A; Reichen J
    Schweiz Med Wochenschr; 1993 Jul; 123(30):1474-81. PubMed ID: 8367707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is ANCA really related to chronic liver disease?
    Sir JU; Kim TY
    Liver Int; 2010 Jan; 30(1):157-8; author reply 158-9. PubMed ID: 19725888
    [No Abstract]   [Full Text] [Related]  

  • 53. Venous thromboembolism with chronic liver disease.
    Saleh T; Matta F; Alali F; Stein PD
    Am J Med; 2011 Jan; 124(1):64-8. PubMed ID: 21187186
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Results of liver scintigraphy in chronic liver diseases].
    Endert G; Banzhaf E; Sensing H
    Z Arztl Fortbild (Jena); 1976 May; 70(9):467-70. PubMed ID: 936673
    [No Abstract]   [Full Text] [Related]  

  • 55. [Activity of cobalt-activated acylase in liver tissue in patients with acute and chronic liver diseases].
    Szewczuk A; Sowa J; Ziomek E; Szczeklik A
    Pol Arch Med Wewn; 1977 Aug; 58(2):133-8. PubMed ID: 905159
    [No Abstract]   [Full Text] [Related]  

  • 56. Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.
    Berry PA; Cross TJ; Thein SL; Portmann BC; Wendon JA; Karani JB; Heneghan MA; Bomford A
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1469-76; quiz 1369. PubMed ID: 17900995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Extended Danish classification of liver- and bile duct diseases (the DASL-code)].
    Schlichting P; Baden H; Juhl E; Poulsen H; Ranek L; Bonnevie O
    Ugeskr Laeger; 1980 Sep; 142(36):2328-9. PubMed ID: 7445120
    [No Abstract]   [Full Text] [Related]  

  • 58. [Trofopar treatment of chronic diffuse diseases of the liver].
    Loginov AS; Nikolaeva AP; Bendikov EA; Blok IuE; Sukhareva GV
    Sov Med; 1989; (7):79-81. PubMed ID: 2799537
    [No Abstract]   [Full Text] [Related]  

  • 59. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 60. Transjugular liver biopsy. An experience based on 500 procedures.
    Brenard R; Horsmans Y; Rahier J; Druez P; Descamps C; Geubel A
    Acta Gastroenterol Belg; 1997; 60(2):138-41. PubMed ID: 9260325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.